Cargando…

Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines

Polycationic resurfaced proteins hold great promise as cell-penetrating bioreagents but their use as carriers for the intracellular delivery of peptide immuno-epitopes has not thus far been explored. Here, we report on the construction and functional characterization of a positively supercharged der...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavazzini, Davide, Spagnoli, Gloria, Mariz, Filipe Colaco, Reggiani, Filippo, Maggi, Stefano, Franceschi, Valentina, Donofrio, Gaetano, Müller, Martin, Bolchi, Angelo, Ottonello, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405434/
https://www.ncbi.nlm.nih.gov/pubmed/36032169
http://dx.doi.org/10.3389/fimmu.2022.958123
_version_ 1784773880121917440
author Cavazzini, Davide
Spagnoli, Gloria
Mariz, Filipe Colaco
Reggiani, Filippo
Maggi, Stefano
Franceschi, Valentina
Donofrio, Gaetano
Müller, Martin
Bolchi, Angelo
Ottonello, Simone
author_facet Cavazzini, Davide
Spagnoli, Gloria
Mariz, Filipe Colaco
Reggiani, Filippo
Maggi, Stefano
Franceschi, Valentina
Donofrio, Gaetano
Müller, Martin
Bolchi, Angelo
Ottonello, Simone
author_sort Cavazzini, Davide
collection PubMed
description Polycationic resurfaced proteins hold great promise as cell-penetrating bioreagents but their use as carriers for the intracellular delivery of peptide immuno-epitopes has not thus far been explored. Here, we report on the construction and functional characterization of a positively supercharged derivative of Pyrococcus furiosus thioredoxin (PfTrx), a thermally hyperstable protein we have previously validated as a peptide epitope display and immunogenicity enhancing scaffold. Genetic conversion of 13 selected amino acids to lysine residues conferred to PfTrx a net charge of +21 (starting from the -1 charge of the wild-type protein), along with the ability to bind nucleic acids. In its unfused form, +21 PfTrx was readily internalized by HeLa cells and displayed a predominantly cytosolic localization. A different intracellular distribution was observed for a +21 PfTrx-eGFP fusion protein, which although still capable of cell penetration was predominantly localized within endosomes. A mixed cytosolic/endosomal partitioning was observed for a +21 PfTrx derivative harboring three tandemly repeated copies of a previously validated HPV16-L2 (aa 20-38) B-cell epitope grafted to the display site of thioredoxin. Compared to its wild-type counterpart, the positively supercharged antigen induced a faster immune response and displayed an overall superior immunogenicity, including a substantial degree of self-adjuvancy. Altogether, the present data point to +21 PfTrx as a promising novel carrier for intracellular antigen delivery and the construction of potentiated recombinant subunit vaccines.
format Online
Article
Text
id pubmed-9405434
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94054342022-08-26 Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines Cavazzini, Davide Spagnoli, Gloria Mariz, Filipe Colaco Reggiani, Filippo Maggi, Stefano Franceschi, Valentina Donofrio, Gaetano Müller, Martin Bolchi, Angelo Ottonello, Simone Front Immunol Immunology Polycationic resurfaced proteins hold great promise as cell-penetrating bioreagents but their use as carriers for the intracellular delivery of peptide immuno-epitopes has not thus far been explored. Here, we report on the construction and functional characterization of a positively supercharged derivative of Pyrococcus furiosus thioredoxin (PfTrx), a thermally hyperstable protein we have previously validated as a peptide epitope display and immunogenicity enhancing scaffold. Genetic conversion of 13 selected amino acids to lysine residues conferred to PfTrx a net charge of +21 (starting from the -1 charge of the wild-type protein), along with the ability to bind nucleic acids. In its unfused form, +21 PfTrx was readily internalized by HeLa cells and displayed a predominantly cytosolic localization. A different intracellular distribution was observed for a +21 PfTrx-eGFP fusion protein, which although still capable of cell penetration was predominantly localized within endosomes. A mixed cytosolic/endosomal partitioning was observed for a +21 PfTrx derivative harboring three tandemly repeated copies of a previously validated HPV16-L2 (aa 20-38) B-cell epitope grafted to the display site of thioredoxin. Compared to its wild-type counterpart, the positively supercharged antigen induced a faster immune response and displayed an overall superior immunogenicity, including a substantial degree of self-adjuvancy. Altogether, the present data point to +21 PfTrx as a promising novel carrier for intracellular antigen delivery and the construction of potentiated recombinant subunit vaccines. Frontiers Media S.A. 2022-08-09 /pmc/articles/PMC9405434/ /pubmed/36032169 http://dx.doi.org/10.3389/fimmu.2022.958123 Text en Copyright © 2022 Cavazzini, Spagnoli, Mariz, Reggiani, Maggi, Franceschi, Donofrio, Müller, Bolchi and Ottonello https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Cavazzini, Davide
Spagnoli, Gloria
Mariz, Filipe Colaco
Reggiani, Filippo
Maggi, Stefano
Franceschi, Valentina
Donofrio, Gaetano
Müller, Martin
Bolchi, Angelo
Ottonello, Simone
Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines
title Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines
title_full Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines
title_fullStr Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines
title_full_unstemmed Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines
title_short Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines
title_sort enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405434/
https://www.ncbi.nlm.nih.gov/pubmed/36032169
http://dx.doi.org/10.3389/fimmu.2022.958123
work_keys_str_mv AT cavazzinidavide enhancedimmunogenicityofapositivelysuperchargedarchaeonthioredoxinscaffoldasacellpenetratingantigencarrierforpeptidevaccines
AT spagnoligloria enhancedimmunogenicityofapositivelysuperchargedarchaeonthioredoxinscaffoldasacellpenetratingantigencarrierforpeptidevaccines
AT marizfilipecolaco enhancedimmunogenicityofapositivelysuperchargedarchaeonthioredoxinscaffoldasacellpenetratingantigencarrierforpeptidevaccines
AT reggianifilippo enhancedimmunogenicityofapositivelysuperchargedarchaeonthioredoxinscaffoldasacellpenetratingantigencarrierforpeptidevaccines
AT maggistefano enhancedimmunogenicityofapositivelysuperchargedarchaeonthioredoxinscaffoldasacellpenetratingantigencarrierforpeptidevaccines
AT franceschivalentina enhancedimmunogenicityofapositivelysuperchargedarchaeonthioredoxinscaffoldasacellpenetratingantigencarrierforpeptidevaccines
AT donofriogaetano enhancedimmunogenicityofapositivelysuperchargedarchaeonthioredoxinscaffoldasacellpenetratingantigencarrierforpeptidevaccines
AT mullermartin enhancedimmunogenicityofapositivelysuperchargedarchaeonthioredoxinscaffoldasacellpenetratingantigencarrierforpeptidevaccines
AT bolchiangelo enhancedimmunogenicityofapositivelysuperchargedarchaeonthioredoxinscaffoldasacellpenetratingantigencarrierforpeptidevaccines
AT ottonellosimone enhancedimmunogenicityofapositivelysuperchargedarchaeonthioredoxinscaffoldasacellpenetratingantigencarrierforpeptidevaccines